News Archive

/static/apps/cms/news/1274/Dadhania_Vipulkumar-coat 500 x 500 .jpg

Using Artificial Intelligence to predict ERG Gene Fusion in Prostate Cancer

May 10, 2022 / Cancer Research

The role of artificial intelligence (AI) in healthcare continues to expand. In a recent issue of BMC Cancer, Dr. Vipulkumar Dadhania (first author) and colleagues published a result of their study Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer. The expert team from the Michigan Center for Translational Pathology developed a deep-learning-based model to predict ERG genomic rearrangements in prostatic adenocarcinomas using only H&E-stained digital slides [...]

FULL STORY
/static/apps/cms/news/1214/Cells-Microscopic-3D-Render-Particles-500x500.jpg

Study Demonstrates a Novel Approach to Target Enhancer-Addicted Cancers

January 4, 2022 / Mctp

A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/888/andi-cani-sq.jpg

Andi Cani becomes Dr. Cani

December 23, 2019 / Phd Program
 

Andi Cani, PhD, successfully defended his thesis entitled “Precision Medicine Approaches to Hormone-Driven Cancer” on December 5, 2019. [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/836/dad and sons 500 x 500 px.jpg

September is Prostate Cancer Awareness Month

September 17, 2019 / Cancer

Every year in the United States, nearly 3 million men hear the words, “You have prostate cancer.” That is 1 in 9 men each year.  The word “cancer” triggers an immediate response in most people…fear, worry about family, denial, and often an increased awareness of one’s mortality. [...]

FULL STORY